123 related articles for article (PubMed ID: 31440994)
1. LPP and RYR2 Gene Polymorphisms Correlate with the Risk and the Prognosis of Astrocytoma.
Chen Q; Sun Y; Wu J; Xiong Z; Niu F; Jin T; Zhao Q
J Mol Neurosci; 2019 Dec; 69(4):628-635. PubMed ID: 31440994
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphism in the 3' untranslated region of LPP is a risk factor for lung cancer: a case-control study.
Yan S; Sun R; Wu S; Jin T; Zhang S; Niu F; Li J; Chen M
BMC Cancer; 2019 Jan; 19(1):35. PubMed ID: 30621612
[TBL] [Abstract][Full Text] [Related]
3. 3'UTR SNPs in the LPP gene associated with Immunoglobulin A nephropathy risk in the Chinese Han population.
Feng Y; Ma C; Zhang Y; Yang X; Zhang D; Xie M; Li W; Wei J
Int Immunopharmacol; 2019 Sep; 74():105668. PubMed ID: 31295688
[TBL] [Abstract][Full Text] [Related]
4. Impact of NR5A2 and RYR2 3'UTR polymorphisms on the risk of breast cancer in a Chinese Han population.
Wei Y; Wang X; Zhang Z; Zhao C; Chang Y; Bian Z; Zhao X
Breast Cancer Res Treat; 2020 Aug; 183(1):1-8. PubMed ID: 32572717
[TBL] [Abstract][Full Text] [Related]
5. The relationship between polymorphisms of XRCC5 genes with astrocytoma prognosis in the Han Chinese population.
He X; Zhu X; Li L; Zhang J; Wu R; Zhang Y; Kang L; Yuan D; Jin T
Oncotarget; 2016 Dec; 7(51):85283-85290. PubMed ID: 27852033
[TBL] [Abstract][Full Text] [Related]
6. Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Wu Y
BMC Neurol; 2019 Nov; 19(1):296. PubMed ID: 31759389
[TBL] [Abstract][Full Text] [Related]
7. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract][Full Text] [Related]
8. The Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population.
Yang Y; Cheng Y; Yang L; Shi G; Chen P; Li L; Fang H; Chen C; Jin T
Cell Mol Neurobiol; 2022 Aug; 42(6):1949-1964. PubMed ID: 33709284
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in the IL4R gene and clinical features are associated with glioma prognosis: Analyses of case-cohort studies.
Jin TB; Du S; Zhu XK; Li G; Ouyang Y; He N; Zhang Z; Zhang Y; Kang L; Yuan D
Medicine (Baltimore); 2016 Aug; 95(31):e4231. PubMed ID: 27495027
[TBL] [Abstract][Full Text] [Related]
10. Impact of ANXA5 polymorphisms on glioma risk and patient prognosis.
Guo X; Song J; Zhao J; Wang B; Yang Z; Sun P; Hu M
J Neurooncol; 2019 Mar; 142(1):11-26. PubMed ID: 30536196
[TBL] [Abstract][Full Text] [Related]
11. Association of ST6GAL1 and CYP19A1 polymorphisms in the 3'-UTR with astrocytoma risk and prognosis in a Chinese Han population.
Wang T; Sun Y; Xiong Z; Wu J; Ding X; Guo X; Shao Y
BMC Cancer; 2021 Apr; 21(1):391. PubMed ID: 33836687
[TBL] [Abstract][Full Text] [Related]
12. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
13. Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Guo X; Ma X; Wu Y
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652449
[TBL] [Abstract][Full Text] [Related]
14. Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.
Perdomo-Pantoja A; Mejía-Pérez SI; Reynoso-Noverón N; Gómez-Flores-Ramos L; Soto-Reyes E; Sánchez-Correa TE; Guerra-Calderas L; Castro-Hernandez C; Vidal-Millán S; Sánchez-Corona J; Taja-Chayeb L; Gutiérrez O; Cacho-Diaz B; Alvarez-Gomez RM; Gómez-Amador JL; Ostrosky-Wegman P; Corona T; Herrera-Montalvo LA; Wegman-Ostrosky T
PLoS One; 2018; 13(11):e0206590. PubMed ID: 30383794
[TBL] [Abstract][Full Text] [Related]
15. DNA repair gene XRCC4 codon 247 polymorphism modified diffusely infiltrating astrocytoma risk and prognosis.
Lin ZH; Chen JC; Wang YS; Huang TJ; Wang J; Long XD
Int J Mol Sci; 2013 Dec; 15(1):250-60. PubMed ID: 24378850
[TBL] [Abstract][Full Text] [Related]
16. Role of PVT1 polymorphisms in the glioma susceptibility and prognosis.
Ding X; Zhao Y; Yuan H; Zhang Y; Gao Y
Eur J Cancer Prev; 2021 Sep; 30(5):400-408. PubMed ID: 33443959
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
Lu Z; Cao Y; Wang Y; Zhang Q; Zhang X; Wang S; Li Y; Xie H; Jiao B; Zhang J
J Neurooncol; 2007 Oct; 85(1):65-73. PubMed ID: 17502998
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):557-565. PubMed ID: 27401155
[TBL] [Abstract][Full Text] [Related]
19. LPP polymorphisms are risk factors for allergic rhinitis in the Chinese Han population.
Wang H; Han H; Niu Y; Li X; Du X; Wang Q
Cytokine; 2022 Nov; 159():156027. PubMed ID: 36084606
[TBL] [Abstract][Full Text] [Related]
20. Association of
Wang XQ; Terry PD; Li Y; Zhang Y; Kou WJ; Wang MX
World J Gastroenterol; 2019 Sep; 25(34):5152-5161. PubMed ID: 31558863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
